Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Genome-Edited iPSC Line Generation for Alzheimer’s & ADRD Models

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract, issued by the National Institutes of Health Olao under the Department of Health and Human Services, focuses on the generation of genetically engineered human induced pluripotent stem cell lines for research into Alzheimer’s Disease-Related Dementias. The project specifically requires the use of the ONE-STEP tagging system to create disease-relevant lines, including the insertion of attP sites. The performance of this contract is centered in Bethesda, with a NAICS code of 541711. The solicitation was posted on August 17, 2026, with a response deadline of August 21, 2026.

General Info

NIH subcontract for genetically engineered stem cell lines researching Alzheimer’s Disease-Related Dementias.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

This scope was carved out of NIH-NOI-PCA-NIA-01590.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Generate genetically engineered human iPSC lines using the ONE-STEP tagging system for Alzheimer’s Disease-Related Dementias (ADRD) research, including attP site insertion and disease-relevant line creation.

Similar Contracts

Same NAICS industry code

NAICS: 541711
Federal
Integrated Phase I/II Clinical Trial DesignThe contract seeks the design and protocol development for an integrated Phase I/II clinical trial to evaluate ibogaine as a potential treatment for opioid use disorder, focusing on safety, optimal dosing, and therapeutic efficacy. The effort requires a comprehensive clinical framework that seamlessly merges the objectives of Phase I, which prioritizes dose escalation and toxicity profiling, with those of Phase II, which assesses preliminary effectiveness in reducing opioid dependence and withdrawal symptoms. The protocol must adhere to rigorous scientific and regulatory standards, incorporating appropriate patient selection criteria, monitoring procedures, endpoints, and risk mitigation strategies for a substance with significant pharmacological and safety considerations. The work is being pursued as a subcontract under the Advanced Research Projects Agency for Health, part of the Department of Health and Human Services, with a NAICS code indicating research and development in the life sciences. The solicitation was posted on August 5, 2026, and responses are due by October 15, 2026. The project is situated within a broader initiative to advance novel therapeutic interventions for the opioid crisis, requiring innovative trial design that balances exploratory research with clinical feasibility. There is no specified set-aside designation or location restriction for performance, indicating flexibility in execution while emphasizing scientific merit and regulatory alignment as key evaluation criteria.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

13 days ago

DEADLINE

in about 2 months
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 541714
New
Federal
Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells
Solicitation # NIH-NOI-PCA-NIA-01590
The National Institute on Aging (NIA), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for the validation and optimization of ONE-STEP tagging in human induced pluripotent stem cells (iPSCs). This acquisition aims to support the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer’s Disease and Related Dementias (CARD) by generating functionally engineered iPSC lines for research into Alzheimer’s disease and related dementias. The project involves high-activity guide identification, Bxb1 mRNA and cargo plasmid delivery optimization, and the generation of ADRD variant, MAPT 4R, and wild-type process-control clones. All deliverables must be repository-ready, meeting strict quality control standards including long-read sequencing, karyotype analysis, and SNP arrays to ensure scientific continuity and data integrity. The government intends to award this contract to The Jackson Laboratory, citing them as the only responsible source capable of meeting the requirements under FAR 6.302-1 and FAR 13.501(a). This determination is based on the laboratory's unique continuity with the existing iNDI program, established workflows for specific background lines, and proven success in large-scale CRISPR/Cas9 engineering. The total estimated contract value is 3,353,115.00 dollars, covering a base year from September 1, 2026, to August 31, 2027, and an option year extending to August 31, 2028. While this is a sole-source intent, the government will consider capability statements from other sources submitted by August 21, 2026, to determine if adequate competition exists.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 14 hours ago

DEADLINE

in 4 days
View Details
NAICS: 811210
New
Federal
Non-competitive Combines Synopsis Solicitation- Se
Solicitation # 75N98026Q01020
The National Institutes of Health Office of the Director intends to award a non-competitive, firm fixed-price contract to USBDB Service Contract Admin for the maintenance of four flow cytometry systems, specifically two A5 SE Standard Cytometers and two S6 Cell Sorters, located at the Vaccine Research Center in Bethesda, Maryland. Conducted under FAR 12.603 and FAR 6.302-3(a)(2)(ii), this acquisition is for commercial services and is not expected to exceed the simplified acquisition threshold. The period of performance is scheduled from September 1, 2026, through August 31, 2027. The scope of work includes comprehensive service coverage consisting of two preventative maintenance inspections and two maintenance kits annually, software revisions, unlimited weekday service visits, and unlimited telephone support. A critical requirement is a 48-hour guaranteed emergency on-site response, with a 500 dollar credit applied if the deadline is missed. Workstation printers are explicitly excluded from coverage. Inspection and acceptance will be performed by the government at the destination in Bethesda, Maryland, ensuring all services meet industry and manufacturer standards. Proposals are due by August 21, 2026, and must include a Unique Entity Identifier, Taxpayer Identification Number, and active SAM registration.
Electronic and Precision Equipment Repair and Maintenance

POSTED

about 14 hours ago

DEADLINE

in 4 days
View Details